Parallel Advisors’s CONMED CNMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.77K | Buy |
50
+36
| +257% | +$1.47K | ﹤0.01% | 3412 |
|
|
2025
Q4 | $568 | Buy |
+14
| New | +$609 | ﹤0.01% | 3381 |
|
|
2025
Q2 | – | Sell |
-8
| Closed | -$483 | – | 3569 |
|
|
2025
Q1 | $483 | Buy |
+8
| New | +$516 | ﹤0.01% | 3241 |
|
|
2024
Q3 | – | Sell |
-17
| Closed | -$1.18K | – | 3408 |
|
|
2024
Q2 | $1.18K | Buy |
17
+4
| +31% | +$292 | ﹤0.01% | 2921 |
|
|
2024
Q1 | $1.04K | Buy |
13
+12
| +1,200% | +$1.07K | ﹤0.01% | 2926 |
|
|
2023
Q4 | $110 | Sell |
1
-68
| -99% | -$7.03K | ﹤0.01% | 3222 |
|
|
2023
Q3 | $6.96K | Buy |
+69
| New | +$7.93K | ﹤0.01% | 2364 |
|
|
2022
Q4 | – | Sell |
-4
| Closed | – | – | 3378 |
|
|
2022
Q3 | $0 | Sell |
4
-6
| -60% | -$566 | ﹤0.01% | 3186 |
|
|
2022
Q2 | $1K | Buy |
10
+1
| +11% | +$120 | ﹤0.01% | 2726 |
|
|
2022
Q1 | $1K | Hold |
9
| – | – | ﹤0.01% | 2718 |
|
|
2021
Q4 | $1K | Hold |
9
| – | – | ﹤0.01% | 2848 |
|
|
2021
Q3 | $1K | Hold |
9
| – | – | ﹤0.01% | 2829 |
|
|
2021
Q2 | $1K | Buy |
+9
| New | +$1.23K | ﹤0.01% | 2705 |
|
|
2020
Q4 | – | Sell |
-89
| Closed | -$7K | – | 2582 |
|
|
2020
Q3 | $7K | Hold |
89
| – | – | ﹤0.01% | 1879 |
|
|
2020
Q2 | $6K | Sell |
89
-11
| -11% | -$765 | ﹤0.01% | 1893 |
|
|
2020
Q1 | $5K | Hold |
100
| – | – | ﹤0.01% | 1883 |
|
|
2019
Q4 | $11K | Buy |
100
+11
| +12% | +$1.17K | ﹤0.01% | 1668 |
|
|
2019
Q3 | $9K | Hold |
89
| – | – | ﹤0.01% | 1707 |
|
|
2019
Q2 | $8K | Hold |
89
| – | – | ﹤0.01% | 1662 |
|
|
2019
Q1 | $7K | Hold |
89
| – | – | ﹤0.01% | 1665 |
|
|
2018
Q4 | $5K | Hold |
89
| – | – | ﹤0.01% | 1567 |
|
|
2018
Q3 | $7K | Hold |
89
| – | – | ﹤0.01% | 1565 |
|
|
2018
Q2 | $6K | Hold |
89
| – | – | ﹤0.01% | 1515 |
|
|
2018
Q1 | $6K | Hold |
89
| – | – | ﹤0.01% | 1466 |
|
|
2017
Q4 | $5K | Hold |
89
| – | – | ﹤0.01% | 1554 |
|
|
2017
Q3 | $4K | Sell |
89
-5
| -5% | -$251 | ﹤0.01% | 1649 |
|
|
2017
Q2 | $5K | Buy |
94
+5
| +6% | +$247 | ﹤0.01% | 1582 |
|
|
2017
Q1 | $5K | Hold |
89
| – | – | ﹤0.01% | 1474 |
|
|
2016
Q4 | $4K | Buy |
+89
| New | +$3.78K | ﹤0.01% | 1417 |
|
Other funds holding CNMD
VPM
VCM
CB
Parallel Advisors's CNMD Position: Q1 2026 in Review
Parallel Advisors increased its CONMED (CNMD) stake by 257% in Q1 2026, buying an estimated $1.47K and bringing the position to 50 shares worth $1.77K. The position accounts for ﹤0.01% of the portfolio, ranked #3412.
Parallel Advisors first reported a position in CNMD in Q4 2016 and has held it in 29 quarters since. The position peaked at $11K in Q4 2019. 236 funds tracked by Wall St. Rank hold CNMD as of Q1 2026.
- Parallel Advisors held 50 shares of CONMED worth $1.77K as of Q1 2026.
- Parallel Advisors bought 36 CONMED shares in Q1 2026, an estimated $1.47K.
- CONMED made up ﹤0.01% of Parallel Advisors's portfolio in Q1 2026, its #3412 holding.
- Parallel Advisors first reported a position in CONMED in Q4 2016 and has held it in 29 quarters since.
- Parallel Advisors's CONMED position peaked at $11K in Q4 2019.
- 236 funds tracked by Wall St. Rank held CONMED as of Q1 2026.
Based on Parallel Advisors's 13F filing for Q1 2026, filed 7 May 2026.